Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2022, titled "Glenmark inks agreement with Astrazeneca to commercialize its product PulmicortRespules in Columbia".
Press Release Feb 14 2022
Filed with NSE · · 3 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Feb 09 2022
- Press Release Jan 28 2022
- Press Release Jan 27 2022
- Press Release Jan 20 2022
- Press Release Jan 17 2022
Later from Glenmark Pharmaceuticals
- Press Release Mar 21 2022
- Press Release Apr 11 2022
- Press Release Apr 25 2022
- Press Release Apr 27 2022
- Press Release May 09 2022
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals